Veno-occlusive disease of the liver after hemopoietic cell transplantation

被引:105
作者
Carreras, E [1 ]
机构
[1] Univ Barcelona, Hosp Clin, Postgrad Sch Haematol Farreras Valenti, BMT Sect,Dept Hematol,Inst Hematol & Oncol, Barcelona, Spain
关键词
veno-occlusive disease of the liver; hemopoietic cell transplantation; hepatic VOD;
D O I
10.1034/j.1600-0609.2000.9r200.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The clinical syndrome of veno-occlusive disease (VOD) after hemopoietic cell transplantation is characterised by jaundice, painful liver enlargement, and fluid retention with weight gain. Cytoreductive therapy is presumably the primary cause of VOD, but several other agents (and a special susceptibility of the liver) can also play a role in its genesis. The risk of VOD can be predicted before BMT by analysing the presence or absence of the main risk factors. For the diagnosis of VOD most teams worldwide apply the clinical criteria developed by both the Seattle and Baltimore teams. Transjugular liver studies and some biological markers can help establish a correct differential diagnosis. In most cases clinical manifestations improve after several days, but 20-25% of patients could die of VOD. Data regarding whether or not pharmacological prophylactic measures are effective are contradictory. There a few therapeutical approaches directed towards the improvement of venular occlusion; recombinant tissue plasminogen activator and defibrotide can solve some cases of severe VOD.
引用
收藏
页码:281 / 291
页数:11
相关论文
共 124 条
[1]   TRANSFORMING GROWTH-FACTOR-BETA AS A PREDICTOR OF LIVER AND LUNG FIBROSIS AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ADVANCED BREAST-CANCER [J].
ANSCHER, MS ;
PETERS, WP ;
REISENBICHLER, H ;
PETROS, WP ;
JIRTLE, RL .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (22) :1592-1598
[2]  
ATTAL M, 1993, BLOOD, V82, P732
[3]  
ATTAL M, 1992, BLOOD, V79, P2834
[4]   HEPATIC VENOOCCLUSIVE DISEASE IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION OF SOLID TUMORS AND LYMPHOMAS [J].
AYASH, LJ ;
HUNT, M ;
ANTMAN, K ;
NADLER, L ;
WHEELER, C ;
TAKVORIAN, T ;
ELIAS, A ;
ANTIN, JH ;
GREENOUGH, T ;
EDER, JP .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (10) :1699-1706
[5]   INTERLEUKIN-2 INDUCES ACTIVATION OF COAGULATION AND FIBRINOLYSIS - RESEMBLANCE TO THE CHANGES SEEN DURING EXPERIMENTAL ENDOTOXEMIA [J].
BAARS, JW ;
DEBOER, JP ;
WAGSTAFF, J ;
ROEM, D ;
EERENBERGBELMER, AJM ;
NAUTA, J ;
PINEDO, HM ;
HACK, CE .
BRITISH JOURNAL OF HAEMATOLOGY, 1992, 82 (02) :295-301
[6]   SYSTEMIC, SPLANCHNIC AND RENAL HEMODYNAMIC-EFFECTS OF A DOPAMINERGIC DOSE OF DOPAMINE IN PATIENTS WITH CIRRHOSIS [J].
BACQ, Y ;
GAUDIN, C ;
HADENGUE, A ;
ROULOT, D ;
BRAILLON, A ;
MOREAU, R ;
LEBREC, D .
HEPATOLOGY, 1991, 14 (03) :483-487
[7]   ENHANCED INVITRO HEMOSTASIS AND REDUCED THROMBOLYSIS IN CYCLOSPORINE-TREATED RENAL-TRANSPLANT RECIPIENTS [J].
BAKER, LRI ;
TUCKER, B ;
KOVACS, IB .
TRANSPLANTATION, 1990, 49 (05) :905-909
[8]  
BAUER KA, 1989, BLOOD, V74, P165
[9]   THE SYNDROME OF HEPATIC VENOOCCLUSIVE DISEASE AFTER MARROW TRANSPLANTATION [J].
BEARMAN, SI .
BLOOD, 1995, 85 (11) :3005-3020
[10]   REGIMEN-RELATED TOXICITY IN PATIENTS UNDERGOING BONE-MARROW TRANSPLANTATION [J].
BEARMAN, SI ;
APPELBAUM, FR ;
BUCKNER, CD ;
PETERSEN, FB ;
FISHER, LD ;
CLIFT, RA ;
THOMAS, ED .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (10) :1562-1568